Dow Up0.64% Nasdaq Up0.68%

Kythera Biopharmaceuticals, Inc. (KYTH)

-NasdaqGS
36.21 Down 0.52(1.42%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development10,962  9,980  9,204  6,969  
Selling General and Administrative7,364  6,121  4,360  4,034  
Non Recurring -  52,757   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (18,326) (68,858) (13,564) (11,003)
Income from Continuing Operations
Total Other Income/Expenses Net51  67  40  32  
Earnings Before Interest And Taxes(18,275)(68,791)(13,524)(10,971)
Interest Expense1,207  654  494  538  
Income Before Tax(19,482)(69,445)(14,018)(11,509)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(19,482)(69,445)(14,018)(11,509)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (19,482) (69,445) (14,018) (11,509)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (19,482) (69,445) (14,018) (11,509)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.